z-logo
open-access-imgOpen Access
Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients
Author(s) -
Vimal K. Derebail,
Patrick H. Nachman,
Nigel S. Key,
Heather Ansede,
Ronald J. Falk,
Wayne D. Rosamond,
Abhijit V. Kshirsagar
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/vbge-xq73
Subject(s) - erythropoiesis , dosing , hemodialysis , phenotype , hemoglobin , medicine , differential (mechanical device) , erythropoietin , anemia , biology , genetics , gene , engineering , aerospace engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here